0001209191-20-011512.txt : 20200221 0001209191-20-011512.hdr.sgml : 20200221 20200221161119 ACCESSION NUMBER: 0001209191-20-011512 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200219 FILED AS OF DATE: 20200221 DATE AS OF CHANGE: 20200221 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: SWAIN PAULA J CENTRAL INDEX KEY: 0001236934 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-12400 FILM NUMBER: 20640129 MAIL ADDRESS: STREET 1: C/O INCYTE CORPORATION STREET 2: 3160 PORTER DRIVE CITY: PALO LATO STATE: CA ZIP: 94304 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: INCYTE CORP CENTRAL INDEX KEY: 0000879169 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731] IRS NUMBER: 943136539 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1801 AUGUSTINE CUT-OFF CITY: WILMINGTON STATE: DE ZIP: 19803 BUSINESS PHONE: 3024986700 MAIL ADDRESS: STREET 1: 1801 AUGUSTINE CUT-OFF CITY: WILMINGTON STATE: DE ZIP: 19803 FORMER COMPANY: FORMER CONFORMED NAME: INCYTE CORP DATE OF NAME CHANGE: 20030318 FORMER COMPANY: FORMER CONFORMED NAME: INCYTE GENOMICS INC DATE OF NAME CHANGE: 20000710 FORMER COMPANY: FORMER CONFORMED NAME: INCYTE PHARMACEUTICALS INC DATE OF NAME CHANGE: 19930902 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2020-02-19 0 0000879169 INCYTE CORP INCY 0001236934 SWAIN PAULA J 1801 AUGUSTINE CUT-OFF WILMINGTON DE 19803 0 1 0 0 EVP, Human Resources Common Stock 2020-02-19 4 M 0 2500 64.55 A 50993 D Common Stock 2020-02-19 4 S 0 2500 80.00 D 48493 D Non-Qualified Stock Option (right to buy) 64.55 2020-02-19 4 M 0 2500 0.00 D 2021-01-20 Common Stock 2500 1639 D This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by reporting person. This includes an aggregate of 20,832 shares of common stock issuable pursuant to previously reported restricted stock units and earned performance stock units that have not vested. Beginning January 21, 2014, options become exercisable in 25 installments, with the first 33.33% vesting after one year and the remainder vesting monthly over two years. /s/ Paula Swain 2020-02-21